Sunnyvale, Calif.-based PQ Bypass, which is developing a percutaneous femoral-popliteal bypass device, said it also named former Abbott (NYSE:ABT) and Johnson & Johnson (NYSE:JNJ) executive Heather Simonsen vice president of global marketing and tapped Gynesonics president & CEO Christopher Owens for the board.
“PQ Bypass has an innovative platform designed to address the unmet needs of patients with long-segment peripheral arterial disease,” Wehrly said. “The company is at a vital inflection point as we prepare for key milestones, including CE Mark and presentation of additional clinical results from the PQ Detour procedure. I am excited about the opportunity to partner with this highly-qualified team to bring this important technology to market.”
PQ Bypass was incubated at California’s Fogarty Institute, named for medical device legend Dr. John Fogarty. Its technology was developed by Dr. James Joye of the El Camino Hospital in Mountain View, Calif., and Dr. Richard Heuser of Phoenix’s St. Luke’s Hospital. Read more
Don’t miss the rest of MassDevice.com’s Personnel Moves – click the page numbers below to read more.